<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Korber N</submitter><funding>Bayerische Forschungsstiftung</funding><pagination>242</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7298696</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Pools of overlapping synthetic peptides are routinely used for ex vivo monitoring of antigen-specific T-cell responses. However, it is rather unlikely that these peptides match those resulting from naturally processed antigens. T-activated proteins have been described as immunogenic and more natural stimulants, since they have to pass through antigen processing and comprise activation of all clinically relevant effector cell populations.&lt;h4>Methods&lt;/h4>We performed comparative analysis of numbers and cytokine expression pattern of CD4 and CD8 T cells after stimulation with recombinant, urea-formulated T-activated EBV-BZLF1, -EBNA3A, and HCMV-IE1, and -pp65 proteins or corresponding overlapping peptide pools. Freshly isolated and cryopreserved PBMC of 30 EBV- and 19 HCMV-</pubmed_abstract><journal>Journal of translational medicine</journal><pubmed_title>Evaluation of T-activated proteins as recall antigens to monitor Epstein-Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting.</pubmed_title><pmcid>PMC7298696</pmcid><funding_grant_id>AZ 1070-13</funding_grant_id><pubmed_authors>Protzer U</pubmed_authors><pubmed_authors>Bauer T</pubmed_authors><pubmed_authors>Korber N</pubmed_authors><pubmed_authors>Behrends U</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of T-activated proteins as recall antigens to monitor Epstein-Barr virus and human cytomegalovirus-specific T cells in a clinical trial setting.</name><description>&lt;h4>Background&lt;/h4>Pools of overlapping synthetic peptides are routinely used for ex vivo monitoring of antigen-specific T-cell responses. However, it is rather unlikely that these peptides match those resulting from naturally processed antigens. T-activated proteins have been described as immunogenic and more natural stimulants, since they have to pass through antigen processing and comprise activation of all clinically relevant effector cell populations.&lt;h4>Methods&lt;/h4>We performed comparative analysis of numbers and cytokine expression pattern of CD4 and CD8 T cells after stimulation with recombinant, urea-formulated T-activated EBV-BZLF1, -EBNA3A, and HCMV-IE1, and -pp65 proteins or corresponding overlapping peptide pools. Freshly isolated and cryopreserved PBMC of 30 EBV- and 19 HCMV-</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jun</publication><modification>2025-04-21T23:28:51.708Z</modification><creation>2020-06-25T07:36:25Z</creation></dates><accession>S-EPMC7298696</accession><cross_references><pubmed>32552697</pubmed><doi>10.1186/s12967-020-02385-x</doi></cross_references></HashMap>